Dr Abdul Mannan/LinkedIn
Sep 21, 2025, 06:16
Dr Abdul Mannan: Finding the Right Balance in Thromboprophylaxis
Dr Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, posted on LinkedIn:
“Clinical Pearls: A Case of Complexity
Finding the right balance in thromboprophylaxis means carefully weighing up APS risks against cancer treatment concerns. While aspirin is our best choice here, we must remember that treating patients isn’t just about following rules. Guidelines help us, but clinical judgment matters too.
Thanks to Dr Zunaira Aamir for sharing this interesting case of a 36-year-old woman with APS (recurrent pregnancy loss, LA positive) and breast cancer on tamoxifen. It shows how we need to think carefully when a patient has multiple risk factors.”
Read full article here.
Stay updated with Hemostasis Today.
-
Aug 24, 2026, 18:13Chokri Ben Lamine: Ruxolitinib – Comprehensive Clinical Reference
-
Aug 24, 2026, 18:10Yazan Abou-Ismail: ClotCast Episode 8 – What Are Platelets?
-
Aug 24, 2026, 17:11Kristin Neves: Which Hematologic Parameters Guide Your PV Treatment Decisions?
-
Aug 24, 2026, 17:00Should Hormone Therapy Automatically Stop After a Thrombosis? – Thrombosis Canada
-
Aug 24, 2026, 16:52Davide Capodanno: 10 Trials to Watch at the ESC Hot Lines
-
Aug 24, 2026, 16:48Mohd Ashhad: The Science Behind a Safe Transfusion
-
Aug 24, 2026, 16:38PCSK9i Is a Powerful Lipid-Lowering Strategy – But Is It Also Anti-Inflammatory?- JACC Journals
-
Aug 24, 2026, 16:36Alejandro González Veliz։ Does ACC/AHA Lesion Complexity Still Matter?
-
Aug 24, 2026, 16:21Kamlesh Darji: Paraneoplastic Syndromes – Tumor with or without Mediator